{"id":"W2139393414","doi":"10.1186/s40345-015-0034-0","title":"Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatments","year":2015,"lang":"en","type":"article","venue":"International Journal of Bipolar Disorders","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Mental Health; National Institute on Alcohol Abuse and Alcoholism; Sunovion; H. Lundbeck A/S; Grupo Ferrer Internacional, S.A; Servier; Agency for Healthcare Research and Quality; American Foundation for Suicide Prevention; European Commission; Supernus Pharmaceuticals; MannKind Corporation; Mitsubishi Tanabe Pharma Corporation; Mallinckrodt Pharmaceuticals; Viropharma; Sucampo Pharmaceuticals; Deutsche Forschungsgemeinschaft; Mayo Foundation for Medical Education and Research; Bundesministerium für Bildung und Forschung; Eli Lilly and Company; Assurex Health; Teva Pharmaceutical Industries; Allergan; AstraZeneca; National Alliance for Research on Schizophrenia and Depression; GlaxoSmithKline; Pfizer","keywords":"Tolerability; Discontinuation; Adjunctive treatment; Medicine; Placebo; Mania; Clinical endpoint; Randomized controlled trial; Clinical Global Impression; Bipolar disorder; Adverse effect; Internal medicine; Mood; Psychiatry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007458825,0.001436645,0.003932104,0.0005820171,0.0003745454,0.001002858,0.001161348,0.002101825,0.004555058],"category_scores_gemma":[0.007064578,0.0006311457,0.001665859,0.0005278222,0.001295386,0.001010074,0.0004778357,0.002641369,0.0005599083],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008122118,"about_ca_system_score_gemma":0.001550259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005163946,"about_ca_topic_score_gemma":0.001407259,"domain_scores_codex":[0.9957551,0.003136906,0.0002951734,0.0002908792,0.0003042106,0.0002176655],"domain_scores_gemma":[0.9961303,0.001630362,0.001051845,0.0003605029,0.0002992082,0.0005277092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9845495,0.002969974,0.0005409313,0.0003214931,0.0008171668,0.00002871077,0.00002045091,0.00013685,0.001275156,0.00009853928,0.0002133796,0.009027846],"study_design_scores_gemma":[0.9622501,0.03559735,0.0008618542,0.00002483946,0.0004047823,0.00001581775,0.000004720644,0.0002527591,0.0001886295,0.00008991782,0.0003036067,0.000005800149],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9522436,0.01003136,0.003765763,0.00139376,0.001696924,0.02620731,0.001234074,0.000209383,0.00321781],"genre_scores_gemma":[0.9706535,0.002332111,0.004721086,0.001136634,0.0009989209,0.01843272,0.0004590802,0.00001999953,0.00124597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007458825,"threshold_uncertainty_score":0.03944647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04010906873077714,"score_gpt":0.327516547875105,"score_spread":0.2874074791443278,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}